Read news as it happens
Create a Rediffmail account
Subscribe via RSS
Cadila launches Remdesivir in India at Rs 2,800 per vial
Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. ......
Guj HC declares BJP minister's election as void
The Gujarat high court on Tuesday declared state BJP minister Bhupendrasinh Chudasama's election in 2017 as void on grounds of malpractice and manipulation. IMAGE: Gujarat minister......
Cadila believes it has silver bullet to fight COVID-19
Can Interferon alfa-2b treat COVID-19 effectively?Sohini Dutt reports. Kindly note the image has been posted only for representational purposes. Photograph: PTI Photo Ahmedabad-based......
Sun Pharma's Dilip Shanghvi takes 99% pay cut
As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore. The founder and managing director (MD) of the country’s largest pharmaceutical firm Sun......
'It was very hard to build an R&D set-up in India'
'In any organisation, a continuous line of leadership, is required.' 'All R&D will be of focus. All the way from Active Pharmaceutical Ingredients to R&D in formulations, to biologics, NCEs,......
bharatiya janata party
united progressive alliance
national democratic alliance
rashtriya swayamsevak sangh
central bureau of investigation
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2021 Rediff.com